LivaNova PLC宣布,其研发的新一代磁共振成像兼容设备预计将于2027年上半年正式推向市场。这一关键时间节点的实现,前提是必须顺利通过美国食品药品监督管理局的审查流程。该设备的推出,标志着公司在神经调节与心血管医疗技术领域迈出了重要一步。
LivaNova PLC宣布,其研发的新一代磁共振成像兼容设备预计将于2027年上半年正式推向市场。这一关键时间节点的实现,前提是必须顺利通过美国食品药品监督管理局的审查流程。该设备的推出,标志着公司在神经调节与心血管医疗技术领域迈出了重要一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.